Should You Buy Rapid Micro Biosystems Inc (RPID) Stock on Wednesday?

The market has been down on Rapid Micro Biosystems Inc (RPID) stock recently. RPID gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Rapid Micro Biosystems Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on RPID!

See Full RPID Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With RPID Stock Today?

Rapid Micro Biosystems Inc (RPID) stock is trading at $2.17 as of 1:45 PM on Wednesday, Nov 30, an increase of $0.01, or 0.56% from the previous closing price of $2.16. The stock has traded between $2.16 and $2.32 so far today. Volume today is low. So far 7,262 shares have traded compared to average volume of 24,675 shares. To see InvestorsObserver's Sentiment Score for Rapid Micro Biosystems Inc click here.

More About Rapid Micro Biosystems Inc

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services. Click Here to get the full Stock Report for Rapid Micro Biosystems Inc stock.